About nGeno
nGeno owns 75% in EcoLife Project. More information: http://ecolife.eu.com/en nGeno owns 81,5% in SmartPatch Project. Wearable device "smart patch" to monitor vital body signs (temperature, HR, blood oxygenation, skin pH, hydrogenation). You can stick smart patch to your skin and monitor yourself. It is IoT (BLE) device, medical silicon, is active - battery. Can work also in passive mode.
Investment Details
Investment Range
Not specified
Investment Stage
Various stages
Industry Focus
Consumer Electronics, Climate, Healthcare (+2 more)
Investor Type
Venture Capital
Investment Focus
Focus Areas
Investment Stages